The MCB Department is pleased to welcome ​​​​​​​ Michael Ward , Professor of Molecular Therapeutics, as our newest faculty member effective July 1, 2026. Dr. Ward is an internationally recognized scientist and physician with expertise in age-related neurodegenerative disorders. Read more about Dr. Ward's research and appointment to UC Berkeley here .